Systane iLux for Dry Eye Syndrome

Recruiting in Palo Alto (17 mi)

Overseen byKeith Wroblewski, MD

Age: 18+

Sex: Any

Travel: May Be Covered

Time Reimbursement: Varies

Trial Phase: Academic

Recruiting

Sponsor: George Washington University

No Placebo Group

Trial Summary

What is the purpose of this trial?This prospective study will investigate the effect of pre-operative Systane iLux system administration in treated cataract induced dry eye disease.

Eligibility Criteria

This trial is for individuals with dry eye disease due to Meibomian Gland Dysfunction who are scheduled for cataract surgery. The study aims to include those who meet specific health criteria, but the exact inclusion and exclusion details aren't provided here.

Inclusion Criteria

I am willing and able to follow the study's requirements.

I am scheduled for cataract surgery due to aging.

I am over 18 years old.

Exclusion Criteria

I have previously used Systane iLux or LipiFlow for my eyes.

I have an abnormality with my eyelids.

I have had an eye injury or chemical burn in the last 3 months.

+8 more

Participant Groups

The trial is testing the effectiveness of a treatment called Systane iLux, which is administered before cataract surgery to see if it can improve symptoms of dry eye caused by Meibomian Gland Dysfunction.

2Treatment groups

Experimental Treatment

Active Control

Group I: Systane iLux TreatmentExperimental Treatment1 Intervention

Systane iLux administration at baseline visit two weeks prior to cataract surgery.

Group II: Control: No Systane iLux TreatmentActive Control1 Intervention

No Systane iLux treatment at baseline visit two weeks prior to cataract surgery.